Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in two main areas, cancer and infectious disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.


Redx Pharma Plc REDX: AIM First day of trading 27/03/2015



http://redxpharma.com/

DYOR - this is only how I see it . . . .
After a loan financial issue in 2017, the suspended shares are out of Administration following a significant drug-right sale for about $40m, which, with a Fundraising, appears to leave them with £12m cash to continue...sp 20p suggests many are wary.
There is much stuff saying good things from the Company and an "independent Report" from Hardman & Co who write these for a living.... however, H won't supply a printed copy...just refer to their Website... which is a fussy alternative IMHO. The Company cannot be contacted - maybe they are having Xmas cheer-up party, or this may be reluctance to provide printed Reports ( just out - see RNS ).

What I do see is that their list of Drug-programme is far short of anything entered Ph1 -which is the most basic...=It doesn't kill healthy patients ( DYOR ). Of course profitable-drugs don't come from thin air, but I'm just not convinced they are discovering much of value to Investors. Maybe they'll be shouting from Rooftops at the next Giddy-go Exhibition, where there is much back-slapping by Execs who are making a gd living already.

Therefore.... the route to lute... may be somewhat long, er IMHO.
Redx (AIM) sp Fell 8% today, currently ~20p